Phase 2 Interstitial Lung Disease Clinical Trials
25 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 25 trials
Recruiting
Phase 2
Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease
Interstitial Lung Disease (ILD)
Region Skane20 enrolled2 locationsNCT07398287
Recruiting
Phase 2
A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients
Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
Sunshine Lake Pharma Co., Ltd.110 enrolled1 locationNCT05139719
Recruiting
Phase 2
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Cardiovascular DiseasesFibrosisLung Diseases+3 more
Pulmovant, Inc.20 enrolled1 locationNCT07333183
Recruiting
Phase 2
Collagen-targeted PET Imaging for Early Interstitial Lung Disease
Interstitial Lung Disease
Massachusetts General Hospital30 enrolled1 locationNCT05417776
Recruiting
Phase 1Phase 2
Feasibility of Semaglutide in Advanced Lung Disease
ObesityChronic Obstructive Pulmonary DiseaseInterstitial Lung Disease+2 more
University of Pennsylvania8 enrolled1 locationNCT05746039
Recruiting
Phase 2
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Progressive Pulmonary FibrosisInterstitial Lung DiseasePulmonary Fibrosis+4 more
Avalyn Pharma Inc.375 enrolled152 locationsNCT06329401
Recruiting
Phase 2
Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease
Lung CancerInterstitial Lung Disease
David Palma98 enrolled3 locationsNCT05986318
Recruiting
Phase 2
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
Interstitial Lung DiseaseLung Diseases, InterstitialIdiopathic Pulmonary Fibrosis
National Institute of Environmental Health Sciences (NIEHS)37 enrolled1 locationNCT06325696
Recruiting
Phase 2
Pulmonary Hypertension SOLAR
COPDInterstitial Lung DiseasePulmonary Arterial Hypertension
Bastiaan Driehuys30 enrolled1 locationNCT04778046
Recruiting
Phase 2Phase 3
Anlotinib Capsules in the Treatment for IPF/PF-ILDs
Interstitial Lung Diseases
First Affiliated Hospital of Wenzhou Medical University30 enrolled1 locationNCT05828953
Recruiting
Phase 2
Platform Clinical Study for Conquering Scleroderma
SclerodermaInterstitial Lung Disease Due to Systemic Disease
Scleroderma Research Foundation, Inc.400 enrolled34 locationsNCT06195072
Recruiting
Phase 2
129Xe MRI Cardiopulmonary
DyspneaInterstitial Lung DiseaseAnemia+3 more
Bastiaan Driehuys125 enrolled1 locationNCT06038630
Recruiting
Phase 2
Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough
Interstitial Lung Disease
Mayo Clinic25 enrolled1 locationNCT05120934
Recruiting
Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
Interstitial Lung Disease
Bastiaan Driehuys445 enrolled1 locationNCT01280994
Recruiting
Phase 2Phase 3
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Scleroderma, SystemicSystemic Sclerosis Associated Interstitial Lung Disease
GlaxoSmithKline300 enrolled131 locationsNCT05878717
Recruiting
Phase 2
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
Interstitial Lung DiseaseCommon Variable Immunodeficiency
Children's Hospital Medical Center, Cincinnati38 enrolled6 locationsNCT04925375
Recruiting
Phase 2
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Interstitial Lung DiseasePulmonary HypertensionSystemic Sclerosis+1 more
Paul Szabolcs8 enrolled3 locationsNCT03630211
Recruiting
Phase 2
Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease
Idiopathic Pulmonary FibrosisPulmonary Fibrosis, Interstitial Lung Disease
Vejle Hospital140 enrolled3 locationsNCT06714123
Recruiting
Phase 2
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Interstitial Lung Disease
aTyr Pharma, Inc.25 enrolled15 locationsNCT05892614
Recruiting
Phase 2
Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
Interstitial Lung DiseaseSystemic SclerosisSystemic Sclerosis With Lung Involvement
Centre hospitalier de l'Université de Montréal (CHUM)35 enrolled3 locationsNCT05785065